Patient outcomes after transcatheter and surgical pulmonary valve replacement for pulmonary regurgitation in patients with repaired tetralogy of Fallot: A quasi-meta-analysis.

Autor:	McRae ME; 1 Medical University of South Carolina, USA.; 2 Guerin Family Congenital Heart Program, Cedars-Sinai Medical Center, USA.; 3 David Geffen School of Medicine, University of California at Los Angeles., Coleman B; 4 Nursing Research Department, Cedars-Sinai Medical Center, USA., Atz TW; 5 College of Medicine, Medical University of South Carolina, USA., Kelechi TJ; 6 College of Nursing, Medical University of South Carolina, USA.
Jazyk:	angličtina
Zdroj:	European journal of cardiovascular nursing [Eur J Cardiovasc Nurs] 2017 Aug; Vol. 16 (6), pp. 539-553. Date of Electronic Publication: 2017 Mar 01.
DOI:	10.1177/1474515117696384
Abstrakt:	Background: Individuals with repaired tetralogy of Fallot develop pulmonary regurgitation that may cause symptoms (dyspnea, chest pain, palpitations, fatigue, presyncope, and syncope), impair functional capacity, and may affect health-related quality of life. Surgical pulmonary valve replacement is the gold standard of treatment although transcatheter pulmonary valve replacement is becoming more common. Patients want to know whether less invasive options are as good. Aims: This analysis aimed to examine the differences in surgical versus transcatheter pulmonary valve replacement effects in terms of physiological/biological variables, symptoms, functional status and health-related quality of life. Methods: This quasi-meta-analysis included 85 surgical and 47 transcatheter pulmonary valve replacement studies published between 1995-2016. Results: In terms of physiological/biological variables, both surgical and transcatheter pulmonary valve replacement improved pulmonary regurgitation and systolic and diastolic right ventricular volume indices but not heart function. In the left heart, only surgical pulmonary valve replacement improved heart function. Only transcatheter pulmonary valve replacement improved left ventricular end-diastolic indices and neither improved endsystolic indices. Only surgery has been demonstrated to decrease QRS duration but there is little evidence of arrhythmia reduction. Symptom change is poorly documented. Functional class improves but exercise capacity generally does not. Some aspects of health-related quality of life improve with surgery and in one small transcatheter pulmonary valve replacement study. Conclusion: Transcatheter and surgical pulmonary valve replacement compare favorably for heart remodeling. Exercise capacity does not change with either technique. Health-related quality of life improves after surgical pulmonary valve replacement. There are numerous gaps in documentation of changes in arrhythmias and symptoms.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu